405090-09-7 Usage
General Description
1-Pyrrolidinecarboxylic acid, 3-[[(methylsulfonyl)oxy]methyl]-, phenylmethyl ester, (3R)- is a chemical compound with the molecular formula C20H25NO4S. It is a derivative of pyrrolidinecarboxylic acid, and the (3R)- designation indicates the stereochemistry of the compound. The presence of the phenylmethyl ester group suggests that this compound may have applications in organic synthesis and pharmaceutical chemistry. The (methylsulfonyl)oxy)methyl group indicates the presence of a sulfonyl group, which can have diverse chemical properties and may be relevant to the compound's reactivity and potential uses. Overall, this compound is likely of interest to researchers and industries working in the fields of organic chemistry, drug discovery, and medicinal chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 405090-09-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 4,0,5,0,9 and 0 respectively; the second part has 2 digits, 0 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 405090-09:
(8*4)+(7*0)+(6*5)+(5*0)+(4*9)+(3*0)+(2*0)+(1*9)=107
107 % 10 = 7
So 405090-09-7 is a valid CAS Registry Number.
405090-09-7Relevant articles and documents
Novel pyrido[2,3-b]indole compounds for the treatment and prophylaxis of bacterial infection
-
Page/Page column 139, (2018/10/25)
The present invention relates to novel compounds of formula (I), wherein R1, R2, R3, R4, R5 and R6 are as described herein, and their pharmaceutically acceptable salt, enantiomer or diastereomer thereof, and compositions including the compounds and methods of using the compounds.
Method of treating addiction or dependence using a ligand for a monoamine receptor or transporter
-
, (2008/06/13)
One aspect of the present invention relates to a method of treating of drug addiction or drug dependence in a mammal, comprising the step of administering to a mammal in need thereof a therapuetically effective amount of a heterocyclic compound, e.g., a 3-substituted piperidine. In a preferred embodiment, the method of the present invention treats cocaine addiction or methamphetamine addiction.
